Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Alinity C Recalled by Abbott Gmbh & Co. KG Due to There is a potential to generate incorrect patient...

Date: May 12, 2020
Company: Abbott Gmbh & Co. KG
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Abbott Gmbh & Co. KG directly.

Affected Products

Alinity C, Processing Module. Chemistry analyzer for in-vitro diagnostics.

Quantity: 421 serial numbers

Why Was This Recalled?

There is a potential to generate incorrect patient results for the following assays: Alkaline Phosphatase, Amylase, Creatine Kinase, and Gamma Glutamyl Transferase.

Where Was This Sold?

This product was distributed to 24 states: AR, CA, CO, FL, GA, KS, KY, LA, MD, MI, MN, MS, MO, NJ, NY, NC, OK, SC, SD, TN, TX, UT, VA, WI

Affected (24 states)Not affected

About Abbott Gmbh & Co. KG

Abbott Gmbh & Co. KG has 18 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report